Drug profile · INN
fosinopril sodium
FOSINOPRIL SODIUM
fosinopril sodium (FOSINOPRIL SODIUM) is a angiotensin-converting enzyme inhibitor. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
Drug details — fosinopril sodium
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 2
- Data quality
- 0.89
Quick answer
fosinopril sodium (FOSINOPRIL SODIUM) is a angiotensin-converting enzyme inhibitor. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Angiotensin-converting enzyme inhibitor
Primary target: Angiotensin-converting enzyme
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is fosinopril sodium?
fosinopril sodium (FOSINOPRIL SODIUM) is a angiotensin-converting enzyme inhibitor. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for fosinopril sodium?
FOSINOPRIL SODIUM is a marketed brand name for fosinopril sodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of fosinopril sodium?
fosinopril sodium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.